GENUS CLOSES $7.8 MILLION IN PRIVATE PLACEMENT

SUNNYVALE, Calif. - August 15, 2002 - Genus, Inc. (Nasdaq: GGNS) announced today
it has closed on $7.8 million in aggregate proceeds through a private placement
of subordinated convertible notes and warrants exercisable for Genus common
stock. The closing represents the receipt of $7.5 million from binding
commitments previously announced on July 31, 2002, and an additional $300,000
from an investor in Genus' January 2002 financing who elected to participate in
this financing on August 14, 2002.

The $7.5 million convertible notes issued in closing the July 31, 2002
commitments are convertible at a price of $1.42 per common share, with no reset
provisions. The $300,000 convertible note issued in closing the August 14, 2002
commitment is convertible at a price of $1.25 per common share, with no reset
provision. All convertible notes pay a seven percent per annum coupon, payable
semi-annually in cash or stock. Warrant coverage for all the warrants is 50
percent. The warrants relating to the $7.5 million convertible notes issued in
closing the July 31, 2002 commitments have a $1.42 exercise price, and the
warrant relating to the $300,000 convertible note issued in closing the August
14, 2002 commitment has a $1.25 exercise price. All warrants have a four-year
term and are callable by the company after one year.

Genus plans to use the private placement proceeds to fund the next phases of
commercialization of its atomic layer deposition technology. Primarily this will
include funding additional inventory, sales and support to address new
customers, working capital, and other general corporate purposes.

SG  Cowen  Securities Corporation acted as placement agent for this transaction.

ABOUT  ALD
Both the semiconductor and data storage industries continue to migrate toward
products with higher density and higher topology. As a result, conformality of
deposited films has also become a critical factor. With current technology
unable to meet the degree of conformality required to manufacture today's
leading-edge technology, the use of Genus' ALD technology in the data storage
market has been adopted. ALD enables manufacturers to extend current
semiconductor and data storage manufacturing processes by offering greater
deposition conformality in smaller feature components with higher aspect ratios.

ABOUT  GENUS
Genus, Inc. manufactures critical deposition processing products for both the
global semiconductor and data storage industries. To enable the production of
intricate micro computer chips and electronic storage devices, Genus offers its
LYNX series production-proven equipment for 200 mm and 300 mm semiconductor
production. They also offer thin film deposition products for chemical vapor
deposition (CVD), atomic layer deposition (ALD), and pre-clean capabilities.

Genus is at the forefront of market and technology developments in the ALD
marketplace, which is gaining acceptance worldwide as a critical technology for
sub 0.13-micron production of computer chips and electronic storage devices.
Genus' customers include semiconductor manufacturers located throughout the
United States, Europe and the Pacific Rim including Korea, Japan and Taiwan.
Founded in 1981, the company is headquartered in Sunnyvale, California. For
additional information visit Genus' web site at www.genus.com. LYNX2(R) and
LYNX3(TM) are trademarks of Genus, Inc.

FORWARD-LOOKING  STATEMENTS
Forward-Looking Statements This press release contains forward-looking
statements regarding the company's expectations regarding future financial and
business performance. These forward-looking statements are subject to a number
of risks and uncertainties. These contingencies include but are not limited to:
actual customer orders received by the company, the extent to which ALD
technology is demanded by the marketplace, the actual number of customer orders
received by the company, the timing of final acceptance of products by
customers, the financial climate and accessibility to financing, general
conditions in the thin film equipment market and in the macro-economy, and the
influence of global political events. Genus assumes no obligation to update this
information. Additional risks and uncertainties are discussed in the
Management's Discussion and Analysis of Results of Operations contained in
Genus' Annual Report on Form 10-K for the fiscal year ended December 31, 2001
and subsequent quarterly reports on Form 10-Q filed with the Securities and
Exchange Commission.

COMPANY  CONTACT:
Shum Mukherjee                          AGENCY CONTACT:
Genus, Inc.                             Lillian Armstrong \ David Barnard
Tel: (408) 747-7120 Ext. 1311           Lippert / Heilshorn & Associates
Fax: (408) 747-7199                     Tel: (415) 433-3777 Ext. 110
Email: smukherjee@genus.com             Email: david@lhai-sf.com


                                                                             iii